Keyword: monoclonal antibodies

Troubles continue to pile up for Immunomedics which has now received a complete response letter for candidate for breast cancer.

French CDMO Novasep says it needs a new fill-finish facility for low-volume biologics, so it will build one at its site in Seneffe, Belgium.

If there was any doubt that the oncology market is set to reach unprecedented heights, FiercePharma's top 15 list of cancer drugs in 2022 should eliminate it.